Redhill Biopharma Ltd
NASDAQ:RDHL
Redhill Biopharma Ltd
Cash from Investing Activities
Redhill Biopharma Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Redhill Biopharma Ltd
NASDAQ:RDHL
|
Cash from Investing Activities
-$30k
|
CAGR 3-Years
91%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
T
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Cash from Investing Activities
$968m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
Taro Pharmaceutical Industries Ltd
NYSE:TARO
|
Cash from Investing Activities
$148.1m
|
CAGR 3-Years
373%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
I
|
InterCure Ltd
TASE:INCR
|
Cash from Investing Activities
-₪147.2m
|
CAGR 3-Years
-58%
|
CAGR 5-Years
-286%
|
CAGR 10-Years
-74%
|
Mediwound Ltd
NASDAQ:MDWD
|
Cash from Investing Activities
-$34.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-28%
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Cash from Investing Activities
-₪20.4m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-15%
|
See Also
What is Redhill Biopharma Ltd's Cash from Investing Activities?
Cash from Investing Activities
-30k
USD
Based on the financial report for Dec 31, 2023, Redhill Biopharma Ltd's Cash from Investing Activities amounts to -30k USD.
What is Redhill Biopharma Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
91%
The average annual Cash from Investing Activities growth rates for Redhill Biopharma Ltd have been 91% over the past three years .